Forte Biosciences, Inc. Common Stock

FBRXNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
21.77 USD
↘ 1.34 (5.80%)🟢LIVE (AS OF 10:33 AM EDT)
🟢Market: OPEN
Open?$23.04
High?$23.40
Low?$21.71
Prev. Close?$23.11
Volume?21.9K
Avg. Volume?338.5K
VWAP?$22.49
Rel. Volume?0.06x
Bid / Ask
Bid?$19.10 × 100
Ask?$25.77 × 100
Spread?$6.67
Midpoint?$22.44
Valuation & Ratios
Market Cap?473.3M
Shares Out?20.5M
Float?7.5M
Float %?60.0%
P/E Ratio?N/A
P/B Ratio?11.24
EPS?-$3.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Themes
Biotech - Drug Development›Immunology & AutoimmuneBiotech - Drug Development›Rare Disease Therapeutics
Employees
22
Market Cap
473.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.fortebiorx.com
Listed
2020-06-16
Address
3060 PEGASUS PARK DRIVE
DALLAS, TX 75247
Phone: (310) 618-6994
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.75Strong
Quick Ratio?2.75Strong
Cash Ratio?2.46Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A▾
P/B?
11.24HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
-5.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-180.2%WEAK▾
ROA?
-112.8%WEAK▾
Cash Flow & Enterprise
FCF?$-59390000
Enterprise Value?$415.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist